Myrio Tx
Kal Gunarathne is a skilled professional in the field of biotechnology with extensive experience in research and laboratory settings. Currently serving as a Research Assistant at Myrio Tx since May 2022 and a Laboratory Technician at Nucleus Network since February 2021, Kal's contributions include processing and handling biological samples according to stringent protocols. Previous roles include Public Health Officer with the Victorian Department of Health, where responsibilities involved disease notification follow-ups and public health recommendations, and a Masters Student at Swinburne University of Technology, focusing on thermophilic esterase genes. Additional experience spans teaching technical subjects in a science laboratory, conducting various laboratory tests in medical and quality control contexts, and providing analytical services in food production. Kal holds a Master's degree in Biotechnology from Swinburne University and a Bachelor's degree in Biotechnology from Bangalore University.
This person is not in any teams
Myrio Tx
Cancer will have no place to hide... Myrio Therapeutics ("Myrio Tx") is about to revolutionize the field of immuno-oncology by enabling antibody-based therapies to attack targets that are inside cells such as mutated cancer-causing and viral proteins. Proteins inside cells are routinely broken down into peptides which are displayed on the cell surface by Major Histocompatibility Complex (MHC), the targets of T-Cells. Myrio Tx’s protein-display system can discover antibodies against difficult to hit targets such as peptide-MHC complexes. This ability increases the number of addressable cancer or viral targets by a factor of ten. Based on fully-human sequences, discovered antibodies can be formatted to fit any purpose, from targeting CAR-T cells, antibody-drug conjugates, bispecifics or traditional antibodies. Myrio Tx's discovery platform can generate high affinity (low nM/pM) and highly selective scFv (antibody fragments) in a matter of days, allowing for rapid evaluation and optimization of product candidates. Myrio Tx is seeking partnerships to fully exploit the potential of its technology whilst also building an in-house portfolio of products.